This website uses cookies, pixels, and similar technologies (“cookies”), some of which are provided by third parties, to enable website features and functionality; measure, analyze, and improve site performance; enhance user experience; record user interactions; and support our advertising and marketing. We and our third-party vendors may monitor, record, and access information and data, including device data, IP address and online identifiers, referring URLs and other browsing information, for these and similar purposes. By clicking “Accept all cookies,” you agree to such purposes. If you continue to browse our site without clicking “Accept all cookies,” or if you click “Reject all cookies,” only cookies necessary to operate and enable default website features and functionalities will be deployed. If you are visiting our Site in the U.S., by using this site or clicking “Accept all cookies,” “Reject all cookies,” or “Preferences,” you acknowledge and agree to our Privacy Policy, Cookie Policy, and Terms of Use.

library

Research & Analysis
/

The biorevolution is here, and the U.S. better be prepared to meet it

Read the Paper
Explores biotech's transformative power beyond healthcare, urging U.S. leadership in the biorevolution amid China's investments.

Dr. Sarah Sewall and Dr. Tara O'Toole's article in the Washington Examiner delves into the transformative power of biotechnologies in revolutionizing various industries beyond healthcare. Highlighting the potential of engineered biology, the authors discuss its role in addressing global challenges such as sustainability, food security, and energy sources. Emphasizing the need for the United States to take the lead in the biorevolution, the piece examines China's substantial investments in biotech and urges the U.S. to prioritize funding, infrastructure, and regulatory frameworks to ensure its competitive edge in this crucial technological frontier.

Read more at Washington Examiner